This website uses cookies to ensure proper functionality of the shopping cart and checkout progress. By continuing to browse the site you are agreeing to the use of cookies. Click here to learn about cookie settings.
Interested in EC Funding, but still need a suitable SME?
The European Community definitely encourages European research groups interested in EC funding to collaborate with small or medium sized enterprises (SME), in order to considerably increase chances for approval.
BIOLOG LSI is permanently looking for interesting areas and themes to bring our signal transduction reagents into practice, and we are interested to develop new tools for special tasks, including medical, cosmetic and diagnostic applications. In addition, our organic synthesis laboratory is eager to take new challenges. Established in 1989, we have considerable experience in successfully launching new structures for the reagent market, and could thus provide the necessary commercial exploitation factor to your EC application. Meanwhile we have already participated in five different projects (MAST III, CRAFT, RTD) and have comprehensive experience in corresponding paperwork, etc.
So, if you consider to start or join a new EC project and still need a suitable, science-orientated SME that fits into the frame, please let us know.
The following benefits and contributions can be offered:
Nearly 700 different nucleobases/nucleosides/nucleotides as regular catalog items
Additional collection (300+) of non-commercial nucleotides, metabolites, precursors, rare structures, etc.
Bulk supply of common cyclic AMP and cyclic GMP analogues
Fully equipped organic synthesis laboratory, and special experience in nucleotide chemistry
Large purification unit for all kinds of chromatography, extraction, desalting, etc.
Long-standing experience in structure-activity analyses
Determination of lipophilicity and prognosis of cell membrane permeability, corresponding structural ranking
Experience in marketing of novel biochemicals, and patenting
Prodrug and masking technologies for polar and charged structures
Long-standing experience in second messenger (cAMP/cGMP) signalling and corresponding literature
Long-standing experience in triphosphates (e.g. for gene sequencing) and corresponding background